Company intelligence / Profile preview
Videregen
Liverpool, England, United Kingdomvideregen.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Videregen is developing regenerative medicine products including an allogeneic, injectable cell therapy for mild to moderate degenerative disc disease and organ replacement products using biological scaffolds with patient's stem cells.
- Therapeutic areas
- PsychiatryImmunologyNeurology
- Modalities
- Cell therapyTissue engineering
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Videregen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Videregen.